The ReSPonD trial - rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson’s disease who have fallen

Three simple clinical tests to accurately predict falls in people with Parkinson's disease

(2013) Serene S. Paul et al.   MOVEMENT DISORDERS

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study

(2012) J. Hippisley-Cox et al.   BMJ-British Medical Journal

Development and Initial Validation of the Iconographical Falls Efficacy Scale

(2011) K. Delbaere et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease

(2010) Carine Karachi et al.   JOURNAL OF CLINICAL INVESTIGATION

Motor complications in Parkinson's disease: Ten year follow-up study

(2010) Iria Cabo López et al.   MOVEMENT DISORDERS

A recommended scale for cognitive screening in clinical trials of Parkinson's disease

(2010) Kelvin L. Chou et al.   MOVEMENT DISORDERS

The MoCA: Well-suited screen for cognitive impairment in Parkinson disease

(2010) J. C. Dalrymple-Alford et al.   NEUROLOGY

Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease

(2010) K. A. Chung et al.   NEUROLOGY

Can cognitive enhancers reduce the risk of falls in older people with Mild Cognitive Impairment? A protocol for a randomised controlled double blind trial

(2009) Manuel Montero-Odasso et al.   BMC Neurology

Reliability of the new freezing of gait questionnaire: Agreement between patients with Parkinson's disease and their carers

(2009) Alice Nieuwboer et al.   GAIT & POSTURE

Fear of falling is independently associated with recurrent falls in patients with Parkinson’s disease: a 1-year prospective study

(2009) Margaret K. Y. Mak et al.   JOURNAL OF NEUROLOGY

CAN COGNITIVE ENHANCERS REDUCE THE RISK OF FALLS IN PEOPLE WITH DEMENTIA? AN OPEN-LABEL STUDY WITH CONTROLS

(2009) Manuel Montero-Odasso et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Clinical and physiological assessments for elucidating falls risk in Parkinson's disease

(2009) Mark D. Latt et al.   MOVEMENT DISORDERS

History of falls in Parkinson disease is associated with reduced cholinergic activity

(2009) N. I. Bohnen et al.   NEUROLOGY

GALANTAMINE IMPROVES GAIT PERFORMANCE IN PATIENTS WITH ALZHEIMER'S DISEASE

(2008) Frédéric Assal et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Determinants of disability and quality of life in mild to moderate Parkinson disease

(2008) D. Muslimovic et al.   NEUROLOGY

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients

(2008) Juha O. Rinne et al.   PARKINSONISM & RELATED DISORDERS